References
- GallagherMJYilmazTCervantes-CastañedaRAFosterCSThe characteristic features of optical coherence tomography in posterior uveitisBr J Ophthalmol2007911680168517591668
- OréficeJLCostaRAOréficeFCamposWda Costa-LimaDJrScottIUVitreoretinal morphology in active ocular toxoplasmosis: a prospective study by optical coherence tomographyBr J Ophthalmol20079177378017135336
- HichichiTYoshidaATrempeCLCourse of vitreomacular traction syndromeAm J Ophthalmol199511955617825690
- VinoresSAYoussriAILunaJDUpregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal diseaseHistol Histopathol199712991099046048
- RouvasAPetrouPDouvaliMIntravitreal ranibizumab for the treatment of inflammatory choroidal neovascularizationRetina201131587187921358461
- CornishKSLimLTImrieFManagement of inflammatory choroidal neovascularization (CNV) secondary to punctate inner choroidopathy in a young female of childbearing age with intra-vitreal ranibizumab and half-fluence photodynamic therapy (PDT): a holistic approachSemin Ophthalmol2012271–2293222352824
- DardabounisDAlvanosEGatzioufasZPanosGDIntravitreal ranibizumab in choroidal neovascularisation due to multifocal choroiditis and panuveitis syndromeBMJ Case Rep Epub7172013
- RouvasAPetrouPLadasINeamonitouGVergadosISpontaneous resolution of vitreomacular traction following ranibizumab (Lucentis) injectionEur J Ophthalmol20081830130318320528